We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
KPI (Key Performance Stats) data for antenatal and newborn and young person and adult screening relating to Quarter 3 (1 October to 31 December 2023)
KPI (Key Performance Stats) data for antenatal and newborn and young person and adult screening relating to April 2022 to March 2023
KPI (Key Performance Stats) data for antenatal and newborn and young person and adult screening relating to Quarter 2 (1 July to 30 September 2023)
KPI (Key Performance Stats) data for antenatal and newborn and young person and adult screening relating to Quarter 1 (1 April 2022 - 30 June 2022)
KPI (Key Performance Stats) data for antenatal and newborn and young person and adult screening relating to Quarter 1 (1 April 2023 - 30 June 2023)
KPI (Key Performance Stats) data for antenatal and newborn and young person and adult screening relating to Quarter 4 (1 January 2023 - 31 March 2023)
KPI (Key Performance Stats) data for antenatal and newborn and young person and adult screening relating to Quarter 3 (1 October 2022 - 31 December 2022)
Key Performance Indicator (KPI) data for antenatal and newborn and young person and adult screening relating to quarter 2 (1 July to 30 Sept 2024)
Key Performance Indicator (KPI) data for antenatal and newborn and young person and adult screening relating to quarter 3 (1 Oct to 31 Dec 2024)
Key Performance Indicator (KPI) data for antenatal and newborn and young person and adult screening relating to quarter 1 (1 April to 30 June 2024)
Key Performance Indicator (KPI) data for antenatal and newborn and young person and adult screening relating to quarter 1 (1 April to 30 June 2025)
Key Performance Indicator (KPI) data for antenatal and newborn and young person and adult screening relating to quarter 4 (1 Jan to 31 Mar 2025)
KPI (Key Performance Indicator) data for antenatal and newborn and young person and adult screening relating to Quarter 2 (1 July 2022 - 30 September 2022)
Tables showing deaths registered in Northern Ireland in 2026, up to and including 16 January 2026.
Report of the Isotretinoin Implementation Advisory Expert Working Group regarding recommendations to strengthen the safe use of isotretinoin, the acne medicine commonly known by brand names Roaccutane and Reticutan.
Public Assessment Report on the review of the implementation of the recommendations of the Commission on Human Medicines Isotretinoin Expert Working Group and Isotretinoin Implementation Advisory Expert Working Group.
Outlines the quality and methodology information (QMI) relevant to the healthcare-associated infections (HCAI) accredited official statistics releases.
Trends in meticillin resistant (MRSA) and meticillin susceptible (MSSA) Staphylococcus aureus, Gram-negative bacteraemia and Clostridioides difficile infection.
Monthly analysis estimating excess mortality and mortality rates in England broken down by age, sex, region, upper tier local authority, level of deprivation and cause of death.
Dementia diagnosis counts are published with ethnicity and age breakdowns, prescriptions of anti-psychotic medications and record of receiving a care plan review.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).